Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.
Dolly Sharma, PhD
Advertisement
Articles by Dolly Sharma, PhD
Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.
Advertisement
Latest Updated Articles
Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast CancerPublished: December 24th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds
3
Rheumatoid Arthritis Linked to Elevated Pneumonia Risk, Especially in Seropositive Disease
4
FDA Approves Remibrutinib for Chronic Spontaneous Urticaria
5
